Human urinary carcinogen metabolites: Biomarkers for investigating tobacco and cancer

Carcinogenesis

Volumn 23, Issue 6, 2002, Pages 907-922

  Hecht, Stephen S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; 1 NAPHTHOL; 2 NAPHTHOL; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; 8 HYDROXYDEOXYGUANOSINE; ACETYLCYSTEINE DERIVATIVE; ADENINE DERIVATIVE; AROMATIC AMINE; BENZO[A]PYRENE DERIVATIVE; BIOLOGICAL MARKER; CARCINOGEN; GLUCURONIDE; HETEROCYCLIC AMINE; MUCONIC ACID; N NITROSOPROLINE; NITROSAMINE; PHENANTHRENE DERIVATIVE; SULFIDE; TOBACCO SMOKE;

CANCER; CHEMICAL STRUCTURE; DOSE RESPONSE; ENVIRONMENTAL EXPOSURE; HUMAN; MEDICAL INFORMATION; METABOLITE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SMOKELESS TOBACCO; URINALYSIS;

EID: 0036313209     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/23.6.907     Document Type: Review

References (194)

1. Tobacco or Health: A Global Status Report
2. Mortality from smoking worldwide
3. Oral spit tobacco: Addiction, prevention and treatment
4. Smokeless tobacco
5. Health Effects of Exposure to Environmental Tobacco Smoke: The Report of the California Environmental Protection Agency
6. Tobacco Smoking
7. Cancers weakly related to smoking
8. Cigarette smoking and colorectal cancer mortality in the cancer prevention study II
9. Tobacco smoke carcinogens and lung cancer
10. Environment and cancer: Who are susceptible?
11. Human DNA adduct measurements: State of the art
12. DNA adducts in human tissues: Biomarkers of exposure to carcinogens in tobacco smoke
13. DNA adducts in human carcinogenesis: Etiological relevance and structure-activity relationship
14. Polycyclic aromatic hydrocarbon-DNA adducts in humans: Relevance as biomarkers for exposure and cancer risk
15. Alkylation of macromolecules for detecting mutagenic agents
16. Protein adducts in the molecular dosimetry of chemical carcinogens
17. Five caffeine metabolite ratios to measure tobacco-induced CYP1A2 activity and their relationships with urinary mutagenicity and urine flow
18. Executive Summary
19. Self-regulation of smoking intensity. Smoke yields of the low-nicotine, low-tar cigarettes
20. Doses of nicotine and lung carcinogens delivered to cigarette smokers
21. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine
22. Nicotine metabolic profile in man: Comparison of cigarette smoking and transdermal nicotine
23. Cotinine as a biomarker of environmental tobacco smoke exposure
24. Minor tobacco alkaloids as biomarkers for tobacco use: Comparison of users of cigarettes, smokeless tobacco, cigars and PIPES
25. The less harmful cigarette: A controversial issue. A tribute to Ernst L. Wynder
26. Some Industrial Chemicals and Dyestuffs
27. Analysis and evaluation of trans,trans-muconic acid as a biomarker for benzene exposure
28. Trans,trans-muconic acid, a biological indicator to low levels of environmental benzene: Some aspects of its specificity
29. Suitability of S-phenyl mercapturic acid and trans-trans-muconic acid as biomarkers for exposure to low concentrations of benzene
30. Biological monitoring of exposure to benzene: A comparison between S-phenylmercapturic acid, trans,trans-muconic acid and phenol
31. Determination of S-phenylmercapturic acid in the urine-an improvement in the biological monitoring of benzene exposure
32. Application of the urinary S-phenylmercapturic acid test as a biomarker for low levels of exposure to benzene in industry
33. Validation of biomarkers in humans exposed to benzene: Urine metabolites
34. Biological monitoring of the tobacco-smoke related exposure to benzene
35. Determination of catechol and quinol in the urine of workers exposed to benzene
36. Excretion of 1,2,4-benzenetriol in the urine of workers exposed to benzene
37. Evaluation of biomarkers for occupational exposure to benzene
38. Biomarkers of exposure to low concentrations of benzene: A field assessment
39. Quantitative analysis of catechol and 4-methylcatechol in human urine
40. Toxicology and Carcinogenesis Studies of Naphthalene in F344/N Rats
41. Use of biomarkers in exposure assessment of polycyclic aromatic hydrocarbons
42. Urinary 1-naphthol and 1-pyrenol as indicators of exposure to coal tar products
43. The validity of determination of α-naphthol in urine as a marker for exposure to polycyclic aromatic hydrocarbons
44. Assay of 2-naphthol in human urine by high-performance liquid chromatography
45. Determination of naphthalene metabolites in human urine by liquid chromatography-mass spectrometry with electrospray ionization
46. Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations
47. A study for the proper application of urinary naphthols, new biomarkers for airborne polycyclic aromatic hydrocarbons
48. Polynuclear Aromatic Compounds, Part I, Chemical, Environmental and Experimental Data
49. Advances in tobacco carcinogenesis
50. Structure-activity relationships among tricyclic polynuclear aromatic hydrocarbons
51. Urinary monohydroxylated phenanthrenes and hydroxypyrene - The effects of smoking habits and changes induced by smoking on monooxygenase-mediated metabolism
52. Profile of urinary phenanthrene metabolites in smokers and non-smokers
53. Biological monitoring and biochemical effect monitoring of exposure to polycyclic aromatic hydrocarbons
54. Determination of urinary metabolites of polycyclic aromatic hydrocarbons (PAH) for the risk assessment of PAH-exposed workers
55. Biomonitoring of polycyclic aromatic hydrocarbons in highly exposed coke plant workers by measurement of urinary phenanthrene and pyrene metabolites (phenols and dihydrodiols)
56. Urinary monohydroxylated phenanthrenes and hydroxypyrene-the effects of smoking habits and changes induced by smoking on monooxygenase- mediated metabolism
57. 1-Hydroxypyrene in human urine after exposure to coal tar and a coal tar derived product
58. Biological monitoring of environmental exposure to polycyclic aromatic hydrocarbons; 1-hydroxypyrene in urine of people
59. Benchmark guideline for urinary I-hydroxypyrene as biomarker of occupational exposure to polycyclic aromatic hydrocarbons
60. Smoking and dietary intake of polycyclic aromatic hydrocarbons as sources of interindividual variability in the baseline excretion of 1- hydroxypyrene in urine
61. First international workshop on hydroxypyrene as a biomarker for PAH exposure in man - Summary and conclusions
62. Urinary 1-hydroxypyrene as a marker of exposure to pyrene: An epidemiological survey on a general population group
63. The association of 1-hydroxypyrene-glucuronide in human urine with cigarette smoking and broiled or roasted meat consumption
64. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons
65. Biomonitoring of exposure to polycyclic aromatic hydrocarbons of nonoccupationally exposed persons
66. Seasonal effect on airborne pyrene, urinary 1-hydroxypyrene and benzo[a]pyrene diol epoxide-hemoglobin adducts in the general population
67. Improved HPLC method for analysis of 1-hydroxypyrene in human urine specimens of cigarette smokers
68. CYP1A1, GSTM1 and GSTP1 genetic polymorphisms and urinary 1-hydroxypyrene excretion in non-occupationally exposed individuals
69. Urinary 1-hydroxypyrene as a biomarker of polycyclic aromatic hydrocarbons exposure of workers on a contaminated site: Influence of exposure conditions
70. CYP1A1 and GSTM1 polymorphisms affect urinary 1-hydroxypyrene levels after PAH exposure
71. Biological monitoring of the exposure to polycyclic aromatic hydrocarbons of coke oven workers in relation to smoking and genetic polymorphisms for GSTM1 and GSTT1
72. Urinary 1-hydroxypyrene and 2-naphthol concentrations in male Koreans
73. Polycyclic aromatic hydrocarbon exposure and burden of outdoor workers in Budapest
74. CYP1A1, GSTM1 and GSTP1 genetic polymorphisms and urinary 1- hydroxypyrene excretion in non-occupationally exposed individuals
75. A comparison of the mainstream smoke chemistry and mutagenicity of a representative sample of the US cigarette market with two Kentucky reference cigarettes (KIR4F and KIR5F)
76. Trace determination of urinary 3-hydroxybenzo[a]pyrene by automated column-switching high-performance liquid chromatography
77. High-performance liquid chromatographic method with fluorescence detection for the determination of 3-hydroxybenzo[a]pyrene and 3-hydroxybenz[a]anthracene in the urine of polycyclic aromatic hydrocarbon-exposed workers
78. Human exposure and dosimetry of polycyclic aromatic hydrocarbons in urine from Xuan Wei, China with high lung cancer mortality associated with exposure to unvented coal smoke
79. Determination of r-7,t-8,9,c-10-tetrahydroxy-7,8,9,10-tetrahydrobenzo[a]pyrene in human urine by gas chromatography-negative ion chemical ionization-mass spectrometry
80. Detection of metabolites of polycyclic aromatic hydrocarbons in human urine
81. Interindividual variation in the levels of certain urinary polycyclic aromatic hydrocarbon metabolites following medicinal exposure to coal tar ointment
82. Detection of polycyclic aromatic hydrocarbon metabolites by high-pressure liquid chromatography after purification on immunoaffinity columns in urine from occupationally exposed workers
83. Determination of exposure to polycyclic aromatic hydrocarbons by analysis of human urine
84. Multimethod determination of occupational exposure to polycyclic aromatic hydrocarbons in an aluminum plant
85. Determination of polycyclic aromatic hydrocarbons in the urine, benzo[a]pyrene diol epoxide-DNA adducts in lymphocyte DNA and antibodies to the adducts in sera from coke oven workers
86. Mutagenic activity and polycyclic aromatic hydrocarbon levels in urine of workers exposed to coal tar pitch volatiles in an anode plant
87. An assessment of a urinary biomarker for total human environmental exposure to benzo[a]pyrene
88. Detection and quantification of depurinated benzo[a]pyrene-adducted DNA bases in the urine of cigarette smokers and women exposed to household coal smoke
89. Some Inorganic Substances, Chlorinated Hydrocarbons, Aromatic Amines, N-Nitroso Compounds and Natural Products
90. Some Aromatic Amines, Hydrazine and Related Substances, N-Nitroso Compounds and Miscellaneous Alkylating Agents
91. Carcinogenic aromatic amines and related compounds
92. Monitoring of aromatic amine exposures in workers at a chemical plant with a known bladder cancer excess
93. Identification and quantitative determination of aniline and toluidines in human urine
94. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons
95. Detection of carcinogenic aromatic amines in the urine of non-smokers
96. Detection of carcinogen-DNA adducts in exfoliated urothelial cells of cigarette smokers: Association with smoking, hemoglobin adducts and urinary mutagenicity
97. History, present and future, of heterocyclic amines, cooked food mutagens
98. Identification of urine metabolites of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine following consumption of a single cooked chicken meal in humans
99. Urinary excretion of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in White, African-American and Asian-American men in Los Angeles County
100. Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excreted in the urine
101. Human exposure to endogenous N-nitroso compounds: Quantitative estimates in subjects at high risk for cancer of the oral cavity, oesophagus, stomach and urinary bladder
102. Tobacco smoking, chewing and snuff dipping: Factors contributing to the endogenous formation of N-nitroso compounds
103. N-nitroso compounds and man: Sources of exposure, endogenous formation and occurrence in body fluids
104. Levels of mutagens in the urine of smokers of black and blond tobacco correlate with their risk of bladder cancer
105. Formation of 4-(methylnitrosamino)-4-(3-pyridyl)butyric acid in vitro and in mainstream cigarette smoke
106. Evaluation of 4-(N-methylnitrosamino)-4-(3-pyridyl)butyric acid as a potential monitor of endogenous nitrosation of nicotine and its metabolites
107. Factors influencing the urinary excretion of nitrosodimethylamine and nitrosoproline in human beings
108. Nitrate, nitrite and volatile N-nitroso compounds in the urine of Schistosoma haematobium and Schistosoma mansoni infected patients
109. Nitrate contamination of drinking water: Relationship with HPRT variant frequency in lymphocyte DNA and urinary excretion of N-nitrosamines
110. Biochemistry, biology and carcinogenicity of tobacco-specific N-nitrosamines
111. Tobacco-specific nitrosamines, an important group of carcinogens in tobacco and tobacco smoke
112. 6-methylguanine formation in Clara cells and induction of pulmonary neoplasia in the rat by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
113. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines
114. Tobacco-specific nitrosamines
115. Preparation of pyridine-N-glucuronides of tobacco-specific nitrosamines
116. Tumorigenicity and metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) enantiomers and metabolites in the A/J mouse
117. Metabolites of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in smokers' urine
118. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine
119. Quantitation of urinary metabolites of a tobacco-specific lung carcinogen after smoking cessation
120. Stereochemistry of metabolites of a tobacco-specific lung carcinogen in smokers' urine
121. A metabolite of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of hospital workers exposed to environmental tobacco smoke
122. Metabolites of a tobacco-specific carcinogen in the urine of newborns
123. Metabolites of a tobacco-specific lung carcinogen in the urine of elementary school-aged children
124. Effects of watercress consumption on metabolism of a tobacco-specific lung carcinogen in smokers
125. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers
126. Metabolites of 4-(N-methylnitrosamino)-1-(3-pyridyl)-1-butanone in urine of smokers
127. Effects of indole-3-carbinol on the metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers
128. Does smoking reduction result in reduction of biomarkers associated with harm? A pilot study using a nicotine inhaler
129. Biomonitoring of environmental tobacco smoke (ETS)-related exposure to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
130. Analysis of N- and O-glucuronides of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in human urine
131. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers
132. Metabolites of a tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), in the urine of smokeless tobacco users: Relationship of urinary biomarkers and oral leukoplakia
133. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use
134. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke
135. Metabolites of a tobacco-specific lung carcinogen in the urine of nonsmoking women exposed to environmental tobacco smoke in their homes
136. A tobacco-specific carcinogen in the fetus
137. No association between smoking and the presence of tobacco-specific nitrosamine metabolites in ovarian follicular fluid
138. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen
139. Stereoselective metabolism of nicotine and tobacco-specific N-nitrosamines to 4-hydroxy-4-(3-pyridyl)butanoic acid in rats
140. Quantitation of 4-oxo-4-(3-pyridyl)butanoic acid and enantiomers of 4-hydroxy-4-(3-pyridyl) butanoic acid in human urine: A substantial pathway of nicotine metabolism
141. Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity
142. Interactions of beta-carotene and cigarette smoke in human bronchial epithelial cells
143. Fast quantification of the urinary marker of oxidative stress 8-hydroxy-2′-deoxyguanosine using solid-phase extraction and high-performance liquid chromatography with triple-stage quadrupole mass detection
144. Estimation of oxidative DNA damage in man from urinary excretion of repair products
145. Effect of smoking cessation on oxidative DNA modification estimated by 8-oxo-7,8-dihydro-2′-deoxyguanosine excretion
146. A multi-biomarker approach to study the effects of smoking on oxidative DNA damage and repair and antioxidative defense mechanisms
147. Longitudinal study of urinary 8-hydroxy-2′-deoxyguanosine excretion in healthy adults
148. Life style and urinary 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage: Effects of exercise, working conditions, meat intake, body mass index and smoking
149. Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine and 5-(hydroxymethyl)uracil in smokers
150. Thioether concentration and mutagenicity of urine from cigarette smoker
151. Detection of human exposure to electrophilic compounds by assay of thioether detoxication products in urine
152. Urinary mutagenicity and thioethers in non-smokers: Role of environmental tobacco smoke (ETS) and diet
153. Influence of diet and other factors on urinary levels of thioethers
154. High-performance liquid chromatographic-tandem mass spectrometric determination of 3-hydroxypropylmercapturic acid in human urine
155. Biological monitoring of the tobacco smoke-related exposure to alkylating agents
156. Immunoaffinity purification and gas chromatography-mass spectrometric quantification of 3-alkyladenines in urine: Metabolism studies and basal excretion levels in man
157. Urinary excretion of 3-methyladenine after consumption of fish containing high levels of dimethylamine
158. Urinary excretion of 3-methyladenine and 3-ethyladenine after controlled exposure to tobacco smoke
159. Cigarette smoking and urinary 3-alkyladenine excretion in man
160. Urinary excretion of nitrate, N-nitrosoproline, 3-methyladenine and 7-methylguanine in a Colombian population at high risk for stomach cancer
161. A Rapid Gas Chromatography-Mass Spectrometry Method for the Determination of Urinary 3-Methyladenine: Application in Human Subjects
162. Tobacco Habits Other Than Smoking: Betel-Quid and Areca-Nut Chewing and Some Related Nitrosamines
163. Endogenous formation of N-nitrosoproline and other N-nitrosamino acids in tobacco users
164. Tobacco-specific and betel nut-specific N-nitroso compounds: Occurrence in saliva and urine of betel quid chewers and formation Pi in vitro by nitrosation of betel quid
165. Dosing time with ascorbic acid and nitrate, gum and tobacco chewing, fasting and other factors affecting N-nitrosoproline formation in healthy subjects taking proline with a standard meal
166. 5 leading US commercial brands of moist snuff in 1994 - Assessment of carcinogenic N-nitrosamines
167. Biomonitoring exposure to environmental tobacco smoke (ETS): A critical reappraisal
168. Measurement of the urinary benzene metabolite trans,trans-muconic acid from benzene exposure in humans
169. Benzene exposure, assessed by urinary trans,trans-muconic acid, in urban children with elevated blood lead levels
170. Assessment through environmental and biological measurements of total daily exposure to volatile organic compounds of office workers in Milan, Italy
171. Assessment of the exposure of children to environmental tobacco smoke (ETS) by different methods
172. Trans, trans-Muconic acid as a biomarker of non-occupational environmental exposure to benzene
173. Contribution of tobacco smoke to environmental benzene exposure in Germany
174. Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS)
175. The effect of coal stoves and environmental tobacco smoke on the level of urinary 1-hydroxypyrene
176. Hydroxyphenanthrenes in the urine of non-smokers and smokers
177. Importance of exposure to gaseous and particulate phase components of tobacco smoke in active and passive smokers
178. Uptake of tobacco smoke constituents on exposure to environmental tobacco smoke (ETS)
179. Effects of watercress consumption on urinary metabolites of nicotine in smokers
180. 2′-Hydroxylation of nicotine by cytochrome P450 2A6 and human liver microsomes: Formation of a lung carcinogenic precursor
181. Influence of smoking fewer cigarettes on exposure to tar, nicotine and carbon monoxide
182. Human lung microsomal cytochrome P4501A1 (CYP1A1) activities: Impact of smoking status and CYP1A1, aryl hydrocarbon receptor and glutathione S-transferase M1 genetic polymorphisms
183. Modulation of benzo[a]pyrene diolepoxide-DNA adduct levels in human white blood cells by CYP1A1, GSTM1 and GSTT1 polymorphisms
184. Drug metabolism polymorphisms as modulators of cancer susceptibility
185. The molecular epidemiology of lung cancer
186. The tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone is a β-adrenergic agonist and stimulates DNA synthesis in lung adenocarcinoma via β-adrenergic receptor-mediated release of arachidonic acid
187. Reducing smokeless tobacco use: Feasibility and effects
188. Toombak: A major risk factor for cancer of the oral cavity in Sudan
189. Passive smoking and lung cancer risk: What is the story now?
190. Risk of childhood cancer and adult lung cancer after childhood exposure to passive smoke: A meta-analysis
191. Transplacental carcinogenicity of low doses of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone administered subcutaneously or intratracheally to hamsters